Flemming Bendtsen

Professor

Member of:

Publication year:

All

331 - 332 out of 332Page size: 10

Sort by: Title

Published
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis
Attauabi, M., Madsen, G. R., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2022, In: Digestive and Liver Disease. 54, 9, p. 1168-1178
Research output: Contribution to journal › Review › Research › peer-review
Published
eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease
Pedersen, N., Elkjaer, M., Duricova, D., Burisch, J., Andersen, N. N., Jess, T., Bendtsen, Flemming, Langholz, E., Leotta, S., Knudsen, T., Thorsgaard, N., Munkholm, P. & Dobrzanski, C., 2012, In: Alimentary Pharmacology and Therapeutics. 36, 9, p. 840-849 10 p.
Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...30 31 32 33 34 Next

ID: 13212

386 downloads
Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis
Research output: Contribution to journal › Journal article › Research › peer-review
Published
257 downloads
Bile acids and cardiovascular function in cirrhosis
Research output: Contribution to journal › Review › Research › peer-review
Published
186 downloads
Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis
Research output: Contribution to journal › Journal article › Research › peer-review
Published